BioSpace News Archive

E-Alternative Solutions (EAS), an independent, family-owned innovator of consumer-centric brands and sister company to Swisher International, will showcase Forth™ Cannabidiol (CBD), its new line of hemp-derived, full-spectrum* CBD products at Booth #5567, along with the Leap® Vapor franchise at the Swisher Booth (#2211) at the 2019 National Association of Convenience Stores (NACS) conference in Atlanta, Georgia from October 1-4.

Conduit Health Partners, a patient access company that develops strategies to mitigate risk and help health systems grow, and Central Logic, the leading innovator in Access Center software solutions, announced today at the Patient Flow Summit a preferred partnership to improve care access and operational efficiency for health systems nationwide.

Knopp Biosciences LLC today reported the results of preclinical experiments demonstrating that KB-3061, the lead molecule in the Company’s ion channels platform, restored the function of Kv7 potassium channels in cells engineered to express gene variants that cause the rare, neonatal disease KCNQ2 epileptic encephalopathy (KCNQ2-EE).

On Thursday, October 3, the Tuberous Sclerosis Alliance will hold its 45th Anniversary Gala at The Edison Ballroom in New York City.

IBH Population Health Solutions (Integrated Behavioral Health, Inc.) announced today that three industry veterans have joined its senior leadership team.

Dr. Jeffrey Cummings, a world-renowned Alzheimer’s researcher and leader in clinical trials, has been named the recipient of the 2019 Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery.

The Parkinson’s Foundation today announced an investment of $4.2 million across 46 research grants to advance promising Parkinson’s disease (PD) research in 2019.

Smart pump programming will allow the Medfusion® 4000 pumps to be programmed based on the clinician order, minimizing programming errors.

Financing to Support Advancing Company’s Lead Product Candidate for Muscular Dystrophy

Company has raised total gross proceeds of approximately US$79.37 million from the Offering, before deducting the underwriting commissions and any expenses related to the Offering.